ENHERTU (Trastuzumab Deruxtecan)
- Name: ENHERTU
- Generic Name: Trastuzumab Deruxtecan
- Dosage Form & Strength: For injection: 100 mg lyophilized powder in a single-dose vial
- Manufactured: Daiichi Sankyo, Inc.
Enhertu is a HER2-directed antibody and topoisomerase inhibitor conjugate indicated for the treatment of:
- adult patients with unresectable or metastatic HER2-positive breast cancer
- adult patients with unresectable or metastatic non-small cell lung cancer (NSCLC)
- adult patients with locally advanced or metastatic HER2-positive gastric or gastroesophageal junction adenocarcinoma
- Monitor complete blood counts prior to initiation of enhertu 100 mg and prior to every dose, and as clinically indicated.
- Assess LVEF before initiating therapy with trastuzumab deruxtecan 100 mg and at regular intervals while on therapy as clinically indicated.
- Enhertu can cause fetal harm if used in pregnant women. Females of reproductive age should use effective contraception during treatment with enhertu 100 mg and for at least 7 months after the last dose.
- Due to the risk for serious adverse reactions in a breastfed child, advise women not to breastfeed during therapy with enhertu injection and for 7 months after the last dose.
What documents are required to import ENHERTU to India?
ENHERTU (fam-trastuzumab deruxtecan-nxki) can be imported by patients or government hospitals on the name of the patients only.
The following documentation required to import the product:
- Valid prescription from a qualified doctor.
- Patients diagnostic reports
- Patients id proof (issued by government of India)
How does order be confirmed?
The order will be confirmed only after the receipt of:
- Valid prescription of Doctor
- Import permit if applicable
Is ENHERTU available in India?
ENHERTU is a (prescription drug, prescription medication or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.
IPN (Indian Pharma Network) helps import cancer medicines on the named patient supply (NPS). Indian Pharma Network is facilitator providing input
- On availability in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore and Pune etc.)
- Medicine Price.
- Finding Genuine and reliable source from Canada, Europe, USA and Australia
- Ensuring 100% transparency.
ENHERTU can be made available in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore and Pune and other cities in India.
Indian Pharma Network can facilitate the supply of ENHERTU (prescription medicines) to all locations in the world and in India after fulfilling the legal requirement (if applicable).
Please contact or mail @ – info@indianpharmanetwork.in +91 9310090915- Toll Free – 1800-889-1064 for enhertu price in India.
We take guarantee of quality and delivery anywhere in the world as per the buyer’s requirements
What is the Generic Name for the trade name drug Enhertu® ?
Trastuzumab Deruxtecan is Generic Name for the trade name drug Enhertu®.
What is the Manufacturer Name of Enhertu®?
Enhertu® is manufactured by Daiichi Sankyo, Inc. and AstraZeneca.
Is Enhertu® approved by the FDA?
Yes, Enhertu® is approved by the FDA.
What is the price of Enhertu in India?
To know the Enhertu price in India, you can call or WhatsApp +91-9310090915 or email info@indianpharmanetwork.in.
What is the dosage and form of Enhertu® available?
Enhertu® is available for Injection: 100 mg lyophilized powder in a single-dose vial.
Contact Patient Support
If you have any questions or need any help, contact our Patient Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
Disclaimer
All Trademarks and Brands that appear on the website belong to their respective owners and indianpharmanetwork does not lay any claim on them we only provide Information.